Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Prometheus Laboratories
Information provided by (Responsible Party):
Shradha Agarwal, Mount Sinai School of Medicine
ClinicalTrials.gov Identifier:
NCT01438151
First received: September 20, 2011
Last updated: March 19, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)